Placental site trophoblastic tumor on endometrial polyp: a case report

Placental site trophoblastic tumor (PSTT) is the least common form of gestational trophoblastic disease (GTD), and is biologically different from other forms of GTD. There is a wide clinical spectrum of presentation and behavior ranging from a benign condition to an aggressive disease with a fatal outcome. The authors document a case of PSTT on an endometrial polyp. A 51-year-old woman had abnormal vaginal bleeding for the duration of two months. Her past history included a vaginal delivery in 1998. Her physical examination was normal. Tumor markers were at normal levels. Serum β- human chorionic gonadotropin (hCG) level was 19 mIU/ml and human placental lactogen (hPL) level was in the normal range. The patient underwent an operative hysteroscopy. On examination the uterine cavity appeared to be occupied by a pedunculated polypoid neoformation measuring about 2.5 cm in diameter which was removed and later determined to be a PSTT. There were occasional mitotic figures (0-1/10 high power field). The patient un-derwent hysterectomy and bilateral salpingo-oophorectomy. The patient has no evidence of disease six months after surgery. The authors conclude that a high mitotic count and atypical undifferentiated pathological features are significant poor prognostic factors for survival in PSTT. Hysterectomy represents the gold standard of treatment in all cases of disease confined to the uterus.

Placental site trophoblastic tumor; Gestational trophoblastic disease; Mitosis; Hysterectomy.

[1] Ozaki Y., Shindoh N., Katayama H.: “Placental site trophoblastic tumor: imaging findings”. Radiat. Med., 1999, 17, 427.

[2] Baergen R.N., Rutgers J.L., Young R.H., Osann K., Scully R.E.: “Placental site trophoblastic tumor: study of 55 cases and review of the literature emphasizing factors of prognostic significance”. Gynecol. Oncol., 2006, 100, 511.

[3] Guvendag Guven E.S., Guven S., Esinter I., Ayhan A., Kucukali T., Usubutun A.: “Placental site trophoblastic tumor in a patient with brain and lung metastases”. Int. J. Gynecol. Cancer, 2004, 1483, 558.

[4] Schmid P., Nagai Y., Agarwal R., Hancock B., Savage P.M., Sebire N. J., et al.: “Prognostic markers and long term outcome of placental-site trophoblastic tumours: a retrospective observational study”. Lancet, 2009, 374, 48.

[5] Hassadia A., Gillespie A., Tidy J., Rgn J.A., Wells M., Coleman R., et al.: “Placental site trophoblastic tumor: clinical features and management”. Gynecol. Oncol., 2005, 99, 603.

[6] Chen Y., Zhang X., Xie X.: “Clinical features of 17 cases of placental site trophoblastic tumor”. Int. J. Gynecol. Obstet., 2011, 115, 204.

[7] Piura B., Shaco- Levy R.: “Placental site trophoblastic tumor”. Harefuah, 2007, 146, 62. [In Hebrew].

[8] Marchand F.: “Uber die sogenannten “decidualen” geschwulste im Anschluß an normal Gebart, Abort, Blasenmole und Extrauterine Schwangerschaft”. Monatsschr Geburtshilfe Gynaekol. 1985, 1, 419. [In German].

[9] Kurman R.J., Scully R.E., Norris H.J.: “Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” simulating a malignant tumor”. Cancer, 1976, 38, 1214.

[10] Scully R.E., Young R.H.: “Trophoblastic psudotumor. A reappraisal”. Am. J. Surg. Pathol., 1981, 5, 75.

[11] Feltmate C.M., Genest D.R., Wise L., Bernstein M.R., Goldstein D. P., Berkowitz R.S.: “Placental site trophoblastic tumor: a 17-years experience at the New England Trophoblastic Disease Centre”. Gynecol. Oncol., 2001, 82, 415.

[12] Papadopoulos A.J., Foskett M., Seckl M.J., McNeish I., Paradinas F. J., Rees H., Newlands E.S.: “Twenty five years’ clinical experience with placental site trophoblastic tumors”. J. Reprod. Med., 2002, 47, 460.

[13] Nigam S., Singhal N., Kumar Gupta S., Chhabra D., Manaktala U.: “Placental site trophoblastic tumor in menopausal female. Case report”. Gynecol. Oncol., 2004, 93, 550.

[14] Deng S., Yang X.Y.: “Diagnosis and therapeutics of Placental site trophoblastic tumor”. Zhongguo Yi Xue Yuan Xue Bao, 2002, 24, 418.

[15] Mc Lellan R., Buscema J., Currie J.L., Woodruff J.D.: “Placental site trophoblastic tumor in a postmenopausal woman”. Am. J. Clin. Pathol., 1991, 95, 670.

[16] Swoboda M., Nagl F., Brinninger G., Breitenecker G., Danihel L.: “Placental site trophoblastic tumor appearing three years after menopause”. Geburtsh Fraunheilk, 1997, 57, 46.

[17] Nagelberg S.B., Rosen S.W.: “Clinical and laboratory investigation of a virilized woman with placental trophoblastic tumour”. Obstet. Gynecol., 1985, 65, 527.

[18] Kim S.J.: “Placental site trophoblastic tumor best practice and research”. Clin. Obstet. Gynecol., 2003, 17, 969.

[19] Swisher E., Drescher C.W.: “Metastatic PSTT: Long term remission in a patient treated with EMA/CO chemotherapy”. Gynecol. Oncol., 1998, 68, 62.

[20] How J., Scurry J., Grant P., Sapountzis K., Ostor A., Fortune D., Armes J.: “PSTT: Report of three cases and review of the literature”. Int. J. Gynecol. Cancer, 1995, 5, 241.

[21] Bower M., Newlands E.S., Holden L., Short D., Brock C., Rustin G. J., et al.: “EMA/CO for high risk GTT: results from a cohort study on 272 patients”. J. Clin. Oncol., 1997, 15, 2636.

[22] American Joint Committee on Cancer: “Gestational trophoblastic tumors”. In: Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F. L., Trotti A., (eds).: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, 437.